Diltiazem used as a tacrolimus-sparing agent for treatment of pediatric patients with refractory nephrotic syndrome: a case report and retrospective analysis

• Published in: European journal of clinical pharmacology Vol. 75; no. 4; pp. 591 - 593
• Main Authors: Sun, Jie-Yu, Hu, Ya-Hui, Guo, Hong-Li, Jing, Xia, Xu, Ze-Jun, Sun, Fang, Guo, Hui-Lei, Ding, Xuan-Sheng, Chen, Feng, Xu, Jing
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.04.2019; Springer Nature B.V
• Subjects: Biomedical and Life Sciences; Biomedicine; Child; Child, Preschool; Cytochrome P-450 CYP3A - genetics; Cytochrome P-450 CYP3A - metabolism; Diltiazem; Diltiazem - pharmacology; Diltiazem - therapeutic use; Drug Interactions; Drug Resistance - genetics; Female; Glucocorticoids - pharmacology; Glucocorticoids - therapeutic use; Humans; Immunosuppressive Agents - pharmacology; Immunosuppressive Agents - therapeutic use; Letter to the Editor; Male; Nephrotic syndrome; Nephrotic Syndrome - diagnosis; Nephrotic Syndrome - drug therapy; Nephrotic Syndrome - pathology; Pharmacology/Toxicology; Retrospective Studies; Tacrolimus; Tacrolimus - pharmacology; Tacrolimus - therapeutic use; Treatment Outcome